AryoGen Pharmed

AryoGen Pharmed is a prominent Iranian biopharmaceutical company established in 2009/2010, focused on the research, development, and manufacturing of high-quality biosimilars and recombinant therapeutic proteins. The company operates state-of-the-art cGMP-compliant facilities and is a key member of the CinnaGen Pharmaceutical Group, one of the largest biotech enterprises in the MENA region. The company's portfolio includes biosimilars for critical conditions such as cancer, autoimmune diseases, and hematological disorders, including products like Rituximab, Trastuzumab, Bevacizumab, and recombinant factor VII. AryoGen has achieved international recognition, including GMP certification from the European Medicines Agency (EMA), and actively exports its products to markets across the Middle East, Asia, CIS, and Latin America.